THIS JUST IN!

A news and lifestyle perspective — beyond the obvious!

Latest Pharma Fiasco: EpiPen

Epi-pens

If you work outside Big Pharma, you may consider the profit-margin on EpiPens as an example of price-gouging. The device contains about $1 worth of an activate ingredient, yet a pair of pens can run more than $600. The product is an antidote to an allergic reaction that may occur after a bee sting and other life-threatening events.

(C)WaitTilYouHearThis.com Website Admin (www.WebDesignManageSEO.com).
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: